Microbiosensor is pleased to announce that it won a coveted award at the Medilink Northwest Healthcare Business Awards, held at the Victoria Warehouse in Manchester on Friday 12th February. This annual award ceremony, attended by the sector’s leading business people, clinicians, academics and key opinion leaders, is recognised as a premier event in the region’s Healthcare Technology calendar and the company was delighted to receive the winning prize for the category ‘Start Up Company’ of the Year.

Dr Curtis Dobson, co-founder, comments: “We are absolutely delighted to receive this award. This success reflects the dramatic progress Microbiosensor Limited has made over last 2 to 3 years in translating University research into a tangible product, with the potential to deliver substantial economic and healthcare impacts across Europe. The Award will give the team a further boost as we move forward with our ambitious plans to gain a CE mark for our first product this year.”

Microbiosensor secures SBRI Phase-2 funding to develop its infection monitor for peritoneal dialysis through to early-stage clinical testing.

Microbiosensor and the University of Manchester are awarded a contract under the i4i / NIHR scheme to develop a disposable diagnostic device for monitoring microbial infection and antibiotic resistance in patients with chronic wounds.

Microbiosensor secure SBRI funding to perform proof-of-concept R&D on a novel point-of-care infection monitor for peritoneal dialysis patients.

Microbiosensor in collaboration with the University of Manchester secure Confidence-in-Concept funding from the MRC to explore novel applications for its infection monitoring technology.

Microbiosensor in collaboration with the University of Manchester secures a Follow-on-Fund award from the BBSRC to develop its ground-breaking infection diagnostics technology platform.

Microbiosensor wins the award for the best biomedical project in the North of England at the prestigious BioNow industry awards event.